series-a
Stage
2014
Founded
2
Investors
About
DnaNudge offers a direct-to-consumer genetics service that analyzes DNA from a cheek swab to guide healthier lifestyle choices. The company also developed and deployed a rapid, lab-free point-of-care PCR test for infectious diseases, notably used for COVID-19 diagnostics.
Explore DnaNudge's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.